Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

COVID-19 Updates:      COVID-19 Resources »      Vaccine Update »      Updated Visitor Policy »      What We're Doing to Keep You Safe »

CLINICAL TRIALS
About Clinical Trials Find a Clinical Trial
CLINICAL TRIALS
About Clinical Trials Find a Clinical Trial

Prostate Active Surveillance Study

Trial ID or NCT#

NCT00756665

Status

recruiting iconRECRUITING

Purpose

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This study seeks to discover markers that will identify cancers that are more aggressive from those tumors that grow slowly.

Official Title

Canary Prostate Active Surveillance Study

Eligibility Criteria

Ages Eligible for Study: Older than 21 Years
Sexes Eligible for Study: Male
Accepts Healthy Volunteers: No
View All Criteria

Investigator(s)

James D. Brooks
James D. Brooks
Surgical oncologist, Urologic surgeon
Keith and Jan Hurlbut Professor in the Stanford University School of Medicine
Harcharan Gill
Harcharan Gill
Urologic oncologist, Urologist, Genitourinary specialist
Kathryn Simmons Stamey Professor
Benjamin I. Chung
Benjamin I. Chung
Urologic oncologist, Urologic specialist, Urologist, Genitourinary specialist
Associate Professor of Urology at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Michelle Ferrari
(650) 725-5543

SEND MESSAGE

View on ClinicalTrials.gov